Janku Filip
Chief Medical Officer
Janku Filip has filed 5 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Jul 1, 2026.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.4M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| GLUE | Chief Medical Officer | Sale | 5,407 | $132K | Jul 1 | SEC ↗ | |
| GLUE | Chief Medical Officer | Sale | 6,000 | $138K | Jun 30 | SEC ↗ | |
| GLUE | Chief Medical Officer | Sale | 11,845 | $240K | Jun 25 | SEC ↗ | |
| GLUE | Chief Medical Officer | Sale | 30,000 | $643K | Jun 25 | SEC ↗ | |
| GLUE | Chief Medical Officer | Sale | 9,189 | $179K | Feb 24 | SEC ↗ | |
| GLUE | Chief Medical Officer | Sale | 3,155 | $48K | Jan 5 | SEC ↗ |